louisakewell, Author at European Medical Journal - Page 107 of 153

IgA Nephropathy: New Aspects in Pathophysiology and Pathogenesis

Knowledge of the pathophysiology of immunoglobulin A nephropathy (IgAN) has progressed significantly, with this disease being clearly identified as an…

Primary Focal Segmental Glomerulosclerosis: Why Are Pieces of This Puzzle Still Missing?

Focal segmental glomerulosclerosis (FSGS) can be classified as primary or secondary. Moreover, many causes of primary FSGS have been identified in recent…

Chronic Kidney Disease and Endothelium

The endothelial cell layer is responsible for molecular traffic between the blood and surrounding tissue, and endothelial integrity plays a pivotal role…

EMJ

Supporting CKD Patients at Home

Baxter Symposium from the 52nd European Renal Association – European Dialysis and Transplant Association Congress 2015.

EMJ

Friendly Fat May Help Fight Heart Disease

FAT surrounding our blood vessels can help to fight heart disease, reducing the risk of heart attacks, according to research presented at the…

EMJ

Music May Indeed Possess Charms to Soothe a Savage Breast

MUSIC may emerge as a treatment for heart conditions, according to researchers who have discovered that repeated musical phrases can affect the heart rate.

EMJ

The impact of the Oncotype DX® Recurrence Score® on treatment decisions in breast cancer patients

The results of the Oncotype DX® Breast Cancer Assay are reported as a Recurrence Score® – a number ranging from 0 to 100. This number indicates the…

EMJ

Molecular characterisation of kidney cancer and opportunities for targeted therapies

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sumanta K. Pal, MD, of City of Hope Comprehensive Cancer Center, Duarte, CA…

EMJ

Emerging targeted therapies in haematological malignancies

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, Omaha, NE…

EMJ

New strategies in the treatment of multiple myeloma

Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, reviews the new data presented at the 2015 American Society of Clinical…